Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/1999
11/11/1999CA2327259A1 Human transcriptional regulator molecules
11/11/1999CA2295323A1 Heparanase specific molecular probes and their use in research and medical applications
11/11/1999CA2248963A1 Novel compounds
11/10/1999EP0955361A1 Monoclonal antibodies to tumor-associated antigens, methods for their production, and their use
11/10/1999EP0955360A2 Process for immortalization of cells by means of conditionally transformed helper cells
11/10/1999EP0955301A2 7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylchloline receptors
11/10/1999EP0955059A2 Vaccines containing a saponin and a sterol
11/10/1999EP0955056A1 Recombinant colony stimulating factor-1 for treatment of fungal infection
11/10/1999EP0955055A2 FGF inhibitor, angiogenesis inhibitor and antitumor agent containing complestatin or its derivative as effective ingredient
11/10/1999EP0955052A1 Arsenic hexaoxide (As4O6) for use in cancer therapy and its pharmaceutical composition
11/10/1999EP0955044A2 Method of inhibiting bacterial or fungal growth using a complexing agent
11/10/1999EP0954593A1 Recombinant pox virus for immunization against tumor-associated antigens
11/10/1999EP0954585A2 Human telomerase catalytic subunit
11/10/1999EP0954564A1 Methods for generating cytotoxic t cells in vitro
11/10/1999EP0954535A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
11/10/1999EP0954519A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
11/10/1999EP0954340A1 Targeted combination immunotherapy of cancer
11/10/1999EP0954338A2 Cationic amphiphile/dna complexes
11/10/1999EP0954334A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
11/10/1999EP0954329A1 Method of killing target cells in harvested cell populations with one or more immunotoxins
11/10/1999EP0954313A1 Method for treating tumors having high ldl requirements employing mtp inhibitors
11/10/1999EP0954310A1 Synergistic composition comprising rapamycin and calcitriol
11/10/1999EP0954309A1 Hiv and cancer treatment
11/10/1999EP0954302A1 Therapeutic methods and compositions involving isoflavones
11/10/1999EP0954299A1 Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
11/10/1999EP0773949B1 D-mannose or xylitol esters and their use as drugs
11/10/1999EP0584256B1 Compounds and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors
11/10/1999EP0547165B1 Process for the Preparation of Water-Soluble Camptothecin Analogues, as well as the compounds 10-Hydroxy-11-C(1-6)-alkoxycamptothecin
11/10/1999CN1234806A G protein-coupled receptor antagonists
11/10/1999CN1234792A Nitric ester derivatives and use in treatment of urinary incontinence and other diseases
11/10/1999CN1234791A Inhibition of matrix metalloproteases by 2-('omega'-aroylalkyl)-4-biaryl-oxobutyric acids
11/10/1999CN1234742A Improvements in or relating to diagnostic/therapeutic agents and improvement relating to same
11/10/1999CN1234406A Single-chain multiple antigen-binding molecule, its preparation and use
11/10/1999CN1234405A High-effective broad-spectrum antibody for inhibiting growth and metastasis of tumour
11/10/1999CN1234396A Process for alkylation of hindered sulfamide
11/10/1999CN1234273A Medicine for treatment of middle and late various malignant tumours
11/10/1999CN1234232A External-use medicine composition for treating angioma and preparation method thereof
11/10/1999CN1046290C Process of preparing etoposide phosphate and etoposide
11/10/1999CN1046285C Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
11/10/1999CN1046283C Process for preparation of 9-amino camptothecin
11/10/1999CN1046202C Preparation method for improved freeze dried isocyclophosphamide composition
11/09/1999US5981780 In vivo calcium transport as well as bone calcium mobilization activity, treatment of osteoporosis, possible use in the treatment of cancerous diseases
11/09/1999US5981777 Recovery of taxanes from plant material
11/09/1999US5981762 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors
11/09/1999US5981755 Tachykinin antagonists
11/09/1999US5981754 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity
11/09/1999US5981753 Reacting a naphthalic anhydride with a polyamine and a second naphthalic anhydride
11/09/1999US5981731 Anticarcinogenic/antitumor/antiproliferative agents and diagnostic agents targeted against gene which codes for a protein kinase involved in signal transduction
11/09/1999US5981726 Chimeric and mutationally stabilized tumor-specific B1, B3 and B5 antibody fragments; immunotoxic fusion proteins; and uses thereof
11/09/1999US5981712 Antibody which binds to carboxyamido-triazole resistance protein; for detecting resistance to drug which prevents calcium influx in biological samples/cells
11/09/1999US5981711 Antibodies which bind to protein from putative oncogene; for probes and imaging agents used in diagnosis/prognosis of cancer/tumors; anticarcinogenic/antitumor agents and vaccines
11/09/1999US5981708 Rodent polypeptide which is an autocrine growth factor; for augmenting growth of hematopoeitic stem cells; for antitumor agents to control tumor cell growth
11/09/1999US5981583 For use in the treatment of pathological conditions such as toxic shock, acute inflammatory conditions, acute phase response, atherosclerosis and cancer
11/09/1999US5981574 Phenanthrofuran derivatives
11/09/1999US5981572 Treatment of disorders which arise from a disturbed functioning of systems which are regulated by melatonin; in particular in the treatment of chronobiological disorders, especially in the elderly
11/09/1999US5981541 Substituted heterocycles as anti-tumor agents
11/09/1999US5981533 Pyrazole derivatives and processes for the preparation thereof
11/09/1999US5981525 Indole derivatives useful in the treatment of osteoporosis
11/09/1999US5981521 Tetrahydroisoquinoline derivatives as LHRH antagonists
11/09/1999US5981504 Genetic induction of receptors for targeted radiotherapy
11/09/1999US5981492 Substituted 5-membered ring heterocycles, their preparation and their use
11/09/1999US5981491 Peptides; metalloenzymes; tumor necrosis factor
11/09/1999US5981490 Peptidyl compounds
11/09/1999US5981483 Compositions comprising modulators of cytokines of the TGF-β superfamily
11/09/1999US5981478 Integrin-binding peptides
11/09/1999US5981477 Peptide-metal chelate conjugates
11/09/1999US5981476 Method for treating bladder cancer with a keyhole limpet hemocyanin composition having enhanced anti-tumor activity
11/09/1999US5981471 Administering to human or animal tissue factor pathway inhibitor to inhibit endothelial cell proliferation
11/09/1999US5981470 Administering pharmaceutical agent selected from the group consisting of an angiotensin converting enzyme inhibitor, an angiotensin ii-receptor antagonist, a renin inhibitor, and an angiotensin ii-receptor expression inhibitor
11/09/1999US5981469 As antimicrobial drug, anticarcinogenic agent
11/09/1999US5981277 Polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
11/09/1999US5981232 Mammalian hydrolase; diagnosis, prevention, and treatment of inflammatory diseases and cancer; anticarcinogenic agents; antiinflammatory agents
11/09/1999US5981205 Nuclear Dbf2- related (Ndr) kinases
11/09/1999US5980946 Collagen formulations
11/09/1999US5980913 A tetrapeptides as vaccine adjuvant
11/09/1999US5980896 Antibodies reactive with human carcinomas
11/09/1999US5980895 Immunotoxin containing a disulfide-stabilized antibody fragment joined to a Pseudomonas exotoxin that does not require proteolytic activation
11/09/1999US5980887 Methods for enhancing angiogenesis with endothelial progenitor cells
11/04/1999WO1999055893A1 Retroviral vectors including modified envelope escort proteins
11/04/1999WO1999055867A1 Delayed rectifier potassium channel subunit
11/04/1999WO1999055865A1 Polynucleotides isolated from skin cells and methods for their use
11/04/1999WO1999055859A2 Cd40-interacting and traf-interacting proteins
11/04/1999WO1999055858A2 Human nucleic acid sequences obtained from pancreas tumor tissue
11/04/1999WO1999055855A2 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
11/04/1999WO1999055854A2 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth
11/04/1999WO1999055831A2 Adenoviral vectors for treating disease
11/04/1999WO1999055830A2 Process for synthesizing cox-2 inhibitors
11/04/1999WO1999055734A1 A g-protein coupled 7tm receptor (axor-1)
11/04/1999WO1999055733A1 Cloning of a novel 7tm receptor axor-2
11/04/1999WO1999055725A1 Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors
11/04/1999WO1999055715A2 Polysaccharide-antigen conjugates
11/04/1999WO1999055683A1 N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
11/04/1999WO1999055663A1 Inhibitors of impdh enzyme
11/04/1999WO1999055386A2 Stimulus sensitive gel with radioisotope and methods of making
11/04/1999WO1999055380A1 Nr-CAM GENE, NUCLEIC ACIDS AND NUCLEIC ACID PRODUCTS FOR THERAPEUTIC AND DIAGNOSTIC USES FOR TUMORS
11/04/1999WO1999055377A2 Polyol-ifn-beta conjugates
11/04/1999WO1999055375A1 Stable mitoxantron solutions
11/04/1999WO1999055367A1 INTERNALIZING ErbB2 ANTIBODIES
11/04/1999WO1999055344A1 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies
11/04/1999WO1999055335A1 Substituted tricyclic pyrazole derivatives with protein kinase activity
1 ... 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 ... 2211